This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Genetic Technologies Limited. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Gillian Sue Dite: Innovator in Coronavirus Risk Assessment
Introduction
Gillian Sue Dite is a notable inventor based in Thornbury, Australia. She has made significant contributions to the field of medical technology, particularly in assessing risks associated with coronavirus infections. Her work is crucial in the ongoing fight against viral diseases.
Latest Patents
Gillian holds a patent for "Methods of assessing risk of developing a severe response to coronavirus infection." This patent focuses on methods and systems designed to evaluate the risk of a human subject developing a severe response to a Coronavirus infection, such as SARS-CoV-2. This innovation is vital for improving patient outcomes during health crises.
Career Highlights
Gillian is associated with Genetic Technologies Limited, where she applies her expertise in genetics and medical technology. Her role at the company allows her to work on groundbreaking projects that have the potential to save lives and enhance public health.
Collaborations
Gillian collaborates with esteemed colleagues, including Nicholas Mark Murphy and Richard Allman. Their combined efforts contribute to advancing research and development in the field of genetic technologies.
Conclusion
Gillian Sue Dite is a pioneering inventor whose work in assessing coronavirus infection risks exemplifies the importance of innovation in healthcare. Her contributions are invaluable in the ongoing battle against infectious diseases.